ŷAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Stability Testing in Pharmaceutical Development and Manufacturing - an update for the 21st Century

8 June 2020 08:30 - 9 June 2020 17:00, London, United Kingdom


Introduction
The course content will provide a comprehensive update on current trends which offer substantial potential savings in time and resources in a traditionally costly and complex testing area. Previous participants say that as a result of the course they have been able to significantly reduce testing in some areas, and identified deficiencies in other areas. 

The course will cover:
The impact of the lifecycle approach on product development:
  • The implications of implementation of ICH Q7, Q8, Q9, Q10 and Q11 for stability testing
  • Changes to European GMP guidance with impact on stability testing including    Annexe updates affecting product development, outsourcing and application of Quality Risk Management (QRM)
  • Product Quality Reviews, statistics, and the interpretation of stability data
Recent scientific developments with implications for stability, with a particular focus on cost reduction, shortening of development timelines, and improvements on existing interpretation systems.
  • ASAP - short term high stress testing to get accurate predictions of shelf life with a high degree of confidence – Freethink Technologies’ ASAPprime®
  • Low level impurities and their impact on product stability
  • Manipulation of tablet internal pH to improve product stability
 Who will benefit:
The course is designed for people working in:
· Analytical and Product Development
· Analytical Chemistry
· Stability Testing
· Formulation Development
· Regulatory Affairs
· Pharmaceutical & Biopharmaceutical Production
· Quality Control and Quality Assurance
· Technical Operations
 
Course Programme
Day 1

The course will commence at 8.30 with registration and coffee, course proper will commence at 9.00 and finish at 5.00pm each day
Morning
Introductions
  • Quality by Design and the ICH updates QQ7, Q8, Q9, Q10 and Q11 - implications for stability testing
Afternoon
  • Changes to EU GMP guidance with implications for stability - Chapter 1 and Annexes
  • Product Quality Review and the interpretation of stability data
  • Delegate workshop - reviewing delegate-presented problems
DAY 2
Morning
  • Low level impurities and their impact on drug product stability.
  • ASAP - using short term, high stress testing to get accurate predictions of drug substance and drug product shelf life with high confidence using ASAPprime® software
  • Bracketing and matrixing and accurate data interpretation, using the “Stability” software package from Arlenda
Afternoon
  • Manipulation of tablet internal pH to improve product stability
  • In Silico prediction of drug degradation pathways using the Zeneth software systems
  • Action Planning and Final Q&A.  Delegates are encouraged to send data for analysis prior to the course
Additional Resources
Online access to comprehensive publications including all relevant guidance will be provided as well as colour copies of all presentations and case studies .                                          
 

 
 
Speakers
  • Dr Mark Powell PharmaCourses Ltd, United Kingdom

Venue
DoubleTree Hilton Hotel Angel and Kings Cross

DoubleTree Hilton Hotel Angel and Kings Cross, 60 Pentonville Road, London, N1 9LA, United Kingdom

Useful links

Organised by
PharmaCourses Ltd
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*